Gotowa bibliografia na temat „Acute Leukaemia”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Acute Leukaemia”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Acute Leukaemia"
Sarrou, Evgenia, Laura Richmond, Ruaidhrí J. Carmody, Brenda Gibson i Karen Keeshan. "CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis". International Journal of Molecular Sciences 21, nr 12 (15.06.2020): 4266. http://dx.doi.org/10.3390/ijms21124266.
Pełny tekst źródłaKuzmits, Rudolf, Paul Aiginger, Matthias M. Müller, Günter Steurer i Werner Linkesch. "Assessment of the sensitivity of leukaemic cells to cytotoxic drugs by bioluminescence measurement of ATP in cultured cells". Clinical Science 71, nr 1 (1.07.1986): 81–88. http://dx.doi.org/10.1042/cs0710081.
Pełny tekst źródłaSkarsgård, Lisa Stenman, Mattias K. Andersson, Marta Persson, Ann-Cathrine Larsen, Sarah E. Coupland, Göran Stenman i Steffen Heegaard. "Clinical and genomic features of adult and paediatric acute leukaemias with ophthalmic manifestations". BMJ Open Ophthalmology 4, nr 1 (październik 2019): e000362. http://dx.doi.org/10.1136/bmjophth-2019-000362.
Pełny tekst źródłaNurunnabi, Md, Mosammath Khadiza Mamdu, Ayesha Siddika, Farzana Zafreen, Md Abdul Wahab i Shahana Shermin. "Morphological and Immunophenotypic Analysis in Diagnosis of Acute Leukaemia". Delta Medical College Journal 8, nr 1 (31.03.2022): 15–20. http://dx.doi.org/10.3329/dmcj.v8i1.58958.
Pełny tekst źródłaIvanovic, Mirjana, Olivera Jovicic, Jelena Mandic, Dusko Bogetic i Marcello Maddalone. "Oral manifestations of acute leukaemia". Srpski arhiv za celokupno lekarstvo 139, nr 1-2 (2011): 103–6. http://dx.doi.org/10.2298/sarh1102103i.
Pełny tekst źródłaBudi, Luh Putu Rihayani, Ketut Ariawati i Sianny Herawati. "NEONATAL ACUTE MYELOID LEUKAEMIA". INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 19, nr 3 (14.10.2016): 211. http://dx.doi.org/10.24293/ijcpml.v19i3.417.
Pełny tekst źródłaJeong, E., H. J. Park, J. Y. Lee i B. K. Cho. "Leukaemic macrocheilia in acute myeloblastic leukaemia". British Journal of Dermatology 151, nr 5 (listopad 2004): 1102. http://dx.doi.org/10.1111/j.1365-2133.2004.06242.x.
Pełny tekst źródłaDachi. "Acute Leukaemias in Bauchi State, Northeastern Nigeria: Pattern of Presentations and Clinical Entities". West Africa Journal of Medicine 39, nr 5 (26.06.2022): 497–500. http://dx.doi.org/10.55891/wajm.v39i5.122.
Pełny tekst źródłaOnoja, AM, SA Otene, AT Onoja, IN Ibrahim, A. Mke, I. Okolie, R. Okoli i in. "Prevalence and Nature of Adult Hematological Malignancies Using Bone Marrow Aspiration Cytology in a Tertiary Health Facility: A Seven Year Retrospective Review". Western Journal of Medical and Biomedical Sciences 2, nr 1 (12.04.2021): 39–45. http://dx.doi.org/10.46912/wjmbs.39.
Pełny tekst źródłaSedick, Qanita, Sultan Alotaibi, Saeed Alshieban, Khalid Ben Naheet i Ghaleb Elyamany. "Natural Killer Cell Lymphoblastic Leukaemia/Lymphoma: Case Report and Review of the Recent Literature". Case Reports in Oncology 10, nr 2 (7.07.2017): 588–95. http://dx.doi.org/10.1159/000477843.
Pełny tekst źródłaRozprawy doktorskie na temat "Acute Leukaemia"
Bomken, Simon Nicholas. "Investigating leukaemic propagation in childhood acute lymphoblastic leukaemia". Thesis, University of Newcastle Upon Tyne, 2013. http://hdl.handle.net/10443/1865.
Pełny tekst źródłaBradbury, Dawn Ann. "Factors regulating the autocrine growth of leukaemic cells in acute myeloblastic leukaemia". Thesis, Nottingham Trent University, 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.332817.
Pełny tekst źródłaKnapper, Steven. "FLT3 inhibitors in acute myeloid leukaemia". Thesis, University of Oxford, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.432548.
Pełny tekst źródłaSmith, Matthew Liam Walker. "Mutation profiling in acute myeloid leukaemia". Thesis, Queen Mary, University of London, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.416112.
Pełny tekst źródłaQuinn, M. F. "Homeobox gene expression in acute leukaemia". Thesis, Queen's University Belfast, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.398094.
Pełny tekst źródłaMannari, Deepak. "The genomics of acute myeloid leukaemia : an investigation into the molecular pathogenesis of acute myeloid leukaemia with t(8;21)". Thesis, Queen Mary, University of London, 2012. http://qmro.qmul.ac.uk/xmlui/handle/123456789/8822.
Pełny tekst źródłaSwanepoel, Yolande. "A retrospective study of acute lymphoblastic leukaemia in Paediatric patients at Dr George Mukhari Hospital (2003-2007)". Thesis, University of Limpopo (Medunsa Campus), 2008. http://hdl.handle.net/10386/262.
Pełny tekst źródłaIntroduction: ALL (Acute Lymphoblastic Leukaemia) is the most common leukaemia in childhood. The two most important features predictive of outcome are age and presenting WBC at diagnosis. NCI risk criteria are applied to all children with precursor B-ALL, dividing them into NCI “high risk” (age < 1 year and ≥ 10 yrs, WBC > 50 x 10 9/ ) and NCI “standard risk” (age ≥ 1 year and < 10 yrs, WBC < 50 x 10 9/ ). Gender, immunophenotyping and genetic studies are other features that have been shown to be associated with outcome. Objectives: To determine the correlation between survival outcome of paediatric patients with ALL and different variables, e.g. biological, haematological, immunophenotypic and cytogenetic features at diagnosis, and to determine the duration of survival of a patient since the diagnosis of ALL, at Dr George Mukhari Hospital. Methods: This study was conducted over the period 2003-2007. Children diagnosed with ALL with ages ranging from 1-12 years, were identified. The hospital and laboratory records were analysed retrospectively. Early prognostic features were identified from patient data. Results: Descriptive statistical measures were used to summarize data. Twenty nine paediatric patients with ALL were identified of which 12 were female and 17 were male. The mean age of patients at diagnosis was 7,2 years. The presenting leucocyte count ranged from 2,5 to 325 x 10 9/ . Cytogenetic studies of three patients were available, all of which were unfavourable prognostic factors. Immunophenotyping revealed ten patients with T-cell ALL, 17 patients with B-cell ALL and two patients whose immunophenotype was unknown as recorded results were not available. Twenty one patients’ survival data were known. The longest duration of survival of a patient was 3,7 years. There were seven patients known to be alive at the end of the study period. Conclusion: The cases reported herein and those described in the literature demonstrate the importance of a careful and multidisciplinary approach in the diagnosis and evaluation of paediatric ALL.
Taussig, David. "Characterisation of acute myeloid leukaemia stem cells". Thesis, Queen Mary, University of London, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.424766.
Pełny tekst źródłaCartwright, Cher Suzanne. "Thiopurine Metabolism in Childhood Acute Lymphoblastic Leukaemia". Thesis, University of Sheffield, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.500442.
Pełny tekst źródłaOlwill, Shane. "Annexin II expression in acute myeloid leukaemia". Thesis, University of Ulster, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.274092.
Pełny tekst źródłaKsiążki na temat "Acute Leukaemia"
Olwill, Shane. Annexin II expression in acute myeloid leukaemia. [S.l: The author], 2003.
Znajdź pełny tekst źródłaBarge, A. Acute myeloid leukaemia: The role of haematopoietic growth factors. Macclesfield: Gardner-Caldwell Communications, 1998.
Znajdź pełny tekst źródłaNational Institute for Clinical Excellence. Guidance on the use of imatinib for chronic myeloid leukaemia. London: National Institute for Clinical Excellence, 2003.
Znajdź pełny tekst źródłaNational Institute for Clinical Excellence. Guidance on the use of imatinib for chronic myeloid leukaemia. London: National Institute for Clinical Excellence, 2002.
Znajdź pełny tekst źródłaRaybould, Simon. Spatial analysis of acute lymphoblastic leukaemia in Tyne and Wear. Newcastle upon Tyne: University of Newcastle upon Tyne Centre for Urban and Regional Development Studies, 1987.
Znajdź pełny tekst źródłaRaybould, Simon. Spatial analysis of acute lymphoblastic leukaemia in Tyne and Wear. Newcastle upon Tyne: University of Newcastle upon Tyne Centre for Urban and Regional Development Studies, 1987.
Znajdź pełny tekst źródłaCoyne, Rose Mary. A study of erythropoietin levels in children with common acute lymphoblastic leukaemia. [s.1: The Author], 1989.
Znajdź pełny tekst źródłaMarwah, Sukhjinder Singh. Role of non-transferrin bound iron in acute leukaemia and sickle cell disease. Wolverhampton: University of Wolverhampton, 2001.
Znajdź pełny tekst źródłaMenasce, Lia Patricia. Deletions of the long arm of chromosome 6 in acute lymphoblastic leukaemia and non-Hodgkin's lymphoma. Manchester: University of Manchester, 1994.
Znajdź pełny tekst źródłaFitzmaurice, Richard John. Methods for the detection of haemopoietic cells and the assessment of residula haemopoiesis in acute leukaemia. Manchester: University of Manchester, 1993.
Znajdź pełny tekst źródłaCzęści książek na temat "Acute Leukaemia"
Monfardini, S., K. Brunner, D. Crowther, S. Eckhardt, D. Olive, S. Tanneberger, A. Veronesi, J. M. A. Whitehouse i R. Wittes. "Acute Leukaemia". W Manual of Adult and Paediatric Medical Oncology, 123–37. Berlin, Heidelberg: Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-82489-0_13.
Pełny tekst źródłavon Wolff, Michael, Nicola Gökbuget i Andrea Jarisch. "Acute Leukaemia". W Fertility Preservation in Oncological and Non-Oncological Diseases, 55–64. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-47568-0_8.
Pełny tekst źródłaSchwab, Claire, i Christine J. Harrison. "Acute Lymphoblastic Leukaemia". W Methods in Molecular Biology, 99–117. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61779-074-4_8.
Pełny tekst źródłaWilloughby, M. L. N., i B. Lampkin. "Acute Myeloid Leukaemia". W Cancer in Children, 107–21. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-84722-6_10.
Pełny tekst źródłaRiehm, H., W. Ebell, H. J. Feickert i A. Reiter. "Acute Lymphoblastic Leukaemia". W Cancer in Children, 85–106. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-84722-6_9.
Pełny tekst źródłaSmith, Matthew L., i Thomas McKerrell. "Acute myeloid leukaemia". W The Genetic Basis of Haematological Cancers, 133–202. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118527948.ch3.
Pełny tekst źródłaAndersson, Anna, Anthony V. Moorman, Christine J. Harrison i Charles Mullighan. "Acute lymphoblastic leukaemia". W The Genetic Basis of Haematological Cancers, 223–64. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118527948.ch5.
Pełny tekst źródłaRiehm, H., H. J. Feickert i F. Lampert. "Acute Lymphoblastic Leukaemia". W Cancer in Children, 101–18. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-96889-1_12.
Pełny tekst źródłaBurnett, Alan K., i David Grimwade. "Acute Myeloid Leukaemia". W Postgraduate Haematology, 352–70. Oxford, UK: John Wiley & Sons, Ltd, 2015. http://dx.doi.org/10.1002/9781118853771.ch20.
Pełny tekst źródłaBiondi, Andrea, Anna Maria Testi i Brenda E. S. Gibson. "Acute Promyelocytic Leukaemia". W Molecularly Targeted Therapy for Childhood Cancer, 83–108. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-0-387-69062-9_5.
Pełny tekst źródłaStreszczenia konferencji na temat "Acute Leukaemia"
Bykowska, K., S. Lapaciuk, M. Janczarski, Z. Wegrzynowicz i M. Kopec. "PLASMA FIBRONECTIN IN ACUTE LEUKAEMIAS AND DURING STREPTOKINASE THERAPY". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643557.
Pełny tekst źródłaTirtakusuma, RF, S. Bomken i O. Heidenreich. "Control of Lineage Commitment in Acute Leukaemia". W 30. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch-onkologische Forschung. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1602223.
Pełny tekst źródłaArmenteros-Monterroso, E., L. Zhao, J. de Boer i O. Williams. "Investigating Reptin function in Acute Myeloid Leukaemia". W 30. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch-onkologische Forschung. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1602188.
Pełny tekst źródłaNegi, Amit, Jyoti Rawat, Chirag Gupta, Swapnil Joshi i Mansi Pathak. "Ensemble CAD System for Acute Lymphoblastic Leukaemia Classification". W 2022 3rd International Conference on Intelligent Engineering and Management (ICIEM). IEEE, 2022. http://dx.doi.org/10.1109/iciem54221.2022.9853051.
Pełny tekst źródłaWilde, J. T., S. Kitchen, F. E. Freston i M. Greaves. "A COMPARISON OF D-DIMER AND SERUM FIBRINOGEN/FIBRIN DEGRADATION PRODUCT LEVELS (F.D.P.’s) IN THE INVESTIGATION OF HYPERCOAGULABLE STATES". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643138.
Pełny tekst źródłaMitel, Alina, Carmen Burloiu, Alexandru Capisizu i Monica Luminos. "P137 Case presentation: diagnostic difficulties in acute lymphoblastic leukaemia". W 8th Europaediatrics Congress jointly held with, The 13th National Congress of Romanian Pediatrics Society, 7–10 June 2017, Palace of Parliament, Romania, Paediatrics building bridges across Europe. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2017. http://dx.doi.org/10.1136/archdischild-2017-313273.225.
Pełny tekst źródłaPal, D., H. Blair, S. Boyd, P. Bakelis, A. Elder, S. Moorthy, J. Vormoor i O. Heidenreich. "The human bone marrow (BM) niche in acute leukaemia". W 30. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch-onkologische Forschung. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1602218.
Pełny tekst źródłaClesham, KJ, L. Gasparoli, C. Virely, S. Cantilena, J. De Boer i O. Williams. "Targeting c-MYB in Acute Leukaemia through Drug Repositioning". W 32. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1687158.
Pełny tekst źródłaSkelding, K., J. Gilchrist, E. Pearsall, M. Chi, N. Bowden i L. Lincz. "PO-144 Role of increased expression of brain and acute leukaemia, cytoplasmic (BAALC) in acute myeloid leukaemia (AML) DNA damage repair pathways". W Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.185.
Pełny tekst źródłaInnes, A., T. Barrow, E. Schwalbe, L. Fadhel i S. Gordon. "PO-139 Investigating unusual synthetic lethalgenes in acute lymphoblastic leukaemia". W Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.180.
Pełny tekst źródła